Literature DB >> 3435701

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.

M Sehested1, T Skovsgaard, B van Deurs, H Winther-Nielsen.   

Abstract

Numerous studies have indicated that the plasma membrane plays an important role in the development of resistance to anthracycline and vinca alkaloid drugs (pleiotropic resistance). We have previously shown that pleiotropically resistant Ehrlich ascites tumour cells, which are of epithelial origin, have a significantly increased plasma membrane traffic (endo/exocytosis) to the endosomal compartment compared to sensitive cells. The present study, using the same ultrastructural morphometric technique, has demonstrated a similar significant difference in plasma membrane traffic between daunorubicin resistant and sensitive P388 cell lines (which are of lymphoid origin). Furthermore, we have shown that this difference between the P388 sublines is accompanied by an approximately 4 fold increase in the plasma membrane area participating in recycling together with an increased endosomal volume, number and membrane area in resistant cells. Plasma membrane traffic in resistant cells was significantly inhibited by the calcium channel blocker verapamil, a well known modulator of anthracycline resistance, but unaffected by daunorubicin itself. The confirmation of this phenotype in an additional pleiotropically resistant cell type with a different histogenesis further supports a hypothesis of endosomal drug trapping and vesicular extrusion as a possible resistance mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435701      PMCID: PMC2002395          DOI: 10.1038/bjc.1987.282

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Authors:  R L Juliano; V Ling
Journal:  Biochim Biophys Acta       Date:  1976-11-11

2.  Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.

Authors:  K Dano
Journal:  Cancer Chemother Rep       Date:  1972-12

3.  Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor.

Authors:  K Dano
Journal:  Cancer Chemother Rep       Date:  1971-04

4.  Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient.

Authors:  L D Mayer; M B Bally; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1986-05-09

5.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

6.  Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.

Authors:  E Friche; T Skovsgaard; N I Nissen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells.

Authors:  J M Zamora; W T Beck
Journal:  Biochem Pharmacol       Date:  1986-12-01       Impact factor: 5.858

8.  Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.

Authors:  M Sehested; T Skovsgaard; B van Deurs; H Winther-Nielsen
Journal:  J Natl Cancer Inst       Date:  1987-01       Impact factor: 13.506

9.  Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.

Authors:  M M Cornwell; M M Gottesman; I H Pastan
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

10.  Lysosomotropic agents reverse multiple drug resistance in human cancer cells.

Authors:  N Shiraishi; S Akiyama; M Kobayashi; M Kuwano
Journal:  Cancer Lett       Date:  1986-03       Impact factor: 8.679

View more
  19 in total

1.  Altered intracellular pH regulation in cells with high levels of P-glycoprotein expression.

Authors:  Gregory Young; Luis Reuss; Guillermo A Altenberg
Journal:  Int J Biochem Mol Biol       Date:  2010-06-03

Review 2.  On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.

Authors:  Vasiliki Panagiotopoulou; Giles Richardson; Oliver E Jensen; Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-11-04       Impact factor: 1.733

3.  Intracellular pH and the control of multidrug resistance.

Authors:  S Simon; D Roy; M Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.

Authors:  H M Coley; P R Twentyman; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells.

Authors:  L Warren; A Malarska; J C Jardillier
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 6.  Toward a mechanical control of drug delivery. On the relationship between Lipinski's 2nd rule and cytosolic pH changes in doxorubicin resistance levels in cancer cells: a comparison to published data.

Authors:  Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-03-19       Impact factor: 1.733

7.  Trafficking microenvironmental pHs of polycationic gene vectors in drug-sensitive and multidrug-resistant MCF7 breast cancer cells.

Authors:  Han Chang Kang; Olga Samsonova; You Han Bae
Journal:  Biomaterials       Date:  2010-01-21       Impact factor: 12.479

8.  Cell biological mechanisms of multidrug resistance in tumors.

Authors:  S M Simon; M Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Multi drug resistance-dependent "vacuum cleaner" functionality potentially driven by the interactions between endocytosis, drug size and Pgp-like transporters surface density.

Authors:  Cyril Rauch; Alain Pluen
Journal:  Eur Biophys J       Date:  2007-01-09       Impact factor: 2.095

Review 10.  Killing a cancer: what are the alternatives?

Authors:  Peter Kreuzaler; Christine J Watson
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.